Global Docetaxel Market Research Report 2021

1 Docetaxel Market Overview
1.1 Product Overview and Scope of Docetaxel
1.2 Docetaxel Segment by Type
1.2.1 Global Docetaxel Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 20 mg/ml
1.2.3 40 mg/ml
1.2.4 60 mg/ml
1.3 Docetaxel Segment by Application
1.3.1 Docetaxel Sales Comparison by Application: (2021-2027)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Non-small Cell Lung Cancer
1.3.5 Others
1.4 Global Docetaxel Market Size Estimates and Forecasts
1.4.1 Global Docetaxel Revenue 2016-2027
1.4.2 Global Docetaxel Sales 2016-2027
1.4.3 Docetaxel Market Size by Region: 2016 Versus 2021 Versus 2027

2 Docetaxel Market Competition by Manufacturers
2.1 Global Docetaxel Sales Market Share by Manufacturers (2016-2021)
2.2 Global Docetaxel Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Docetaxel Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Docetaxel Manufacturing Sites, Area Served, Product Type
2.5 Docetaxel Market Competitive Situation and Trends
2.5.1 Docetaxel Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Docetaxel Players Market Share by Revenue
2.5.3 Global Docetaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Docetaxel Retrospective Market Scenario by Region
3.1 Global Docetaxel Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Docetaxel Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Docetaxel Market Facts & Figures by Country
3.3.1 North America Docetaxel Sales by Country
3.3.2 North America Docetaxel Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Docetaxel Market Facts & Figures by Country
3.4.1 Europe Docetaxel Sales by Country
3.4.2 Europe Docetaxel Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Docetaxel Market Facts & Figures by Region
3.5.1 Asia Pacific Docetaxel Sales by Region
3.5.2 Asia Pacific Docetaxel Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Docetaxel Market Facts & Figures by Country
3.6.1 Latin America Docetaxel Sales by Country
3.6.2 Latin America Docetaxel Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Docetaxel Market Facts & Figures by Country
3.7.1 Middle East and Africa Docetaxel Sales by Country
3.7.2 Middle East and Africa Docetaxel Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Docetaxel Historic Market Analysis by Type
4.1 Global Docetaxel Sales Market Share by Type (2016-2021)
4.2 Global Docetaxel Revenue Market Share by Type (2016-2021)
4.3 Global Docetaxel Price by Type (2016-2021)

5 Global Docetaxel Historic Market Analysis by Application
5.1 Global Docetaxel Sales Market Share by Application (2016-2021)
5.2 Global Docetaxel Revenue Market Share by Application (2016-2021)
5.3 Global Docetaxel Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Hengrui Medicine
6.1.1 Hengrui Medicine Corporation Information
6.1.2 Hengrui Medicine Description and Business Overview
6.1.3 Hengrui Medicine Docetaxel Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hengrui Medicine Product Portfolio
6.1.5 Hengrui Medicine Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Docetaxel Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Qilu Pharma
6.3.1 Qilu Pharma Corporation Information
6.3.2 Qilu Pharma Description and Business Overview
6.3.3 Qilu Pharma Docetaxel Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Qilu Pharma Product Portfolio
6.3.5 Qilu Pharma Recent Developments/Updates
6.4 Shenzhen Main Luck Pharma
6.4.1 Shenzhen Main Luck Pharma Corporation Information
6.4.2 Shenzhen Main Luck Pharma Description and Business Overview
6.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Shenzhen Main Luck Pharma Product Portfolio
6.4.5 Shenzhen Main Luck Pharma Recent Developments/Updates
6.5 Jiangsu Aosaikang Pharma
6.5.1 Jiangsu Aosaikang Pharma Corporation Information
6.5.2 Jiangsu Aosaikang Pharma Description and Business Overview
6.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Jiangsu Aosaikang Pharma Product Portfolio
6.5.5 Jiangsu Aosaikang Pharma Recent Developments/Updates

7 Docetaxel Manufacturing Cost Analysis
7.1 Docetaxel Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Docetaxel
7.4 Docetaxel Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Docetaxel Distributors List
8.3 Docetaxel Customers

9 Docetaxel Market Dynamics
9.1 Docetaxel Industry Trends
9.2 Docetaxel Growth Drivers
9.3 Docetaxel Market Challenges
9.4 Docetaxel Market Restraints

10 Global Market Forecast
10.1 Docetaxel Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Docetaxel by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Docetaxel by Type (2022-2027)
10.2 Docetaxel Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Docetaxel by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Docetaxel by Application (2022-2027)
10.3 Docetaxel Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Docetaxel by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Docetaxel by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Docetaxel Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Docetaxel Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Docetaxel Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Docetaxel Covered in This Study
Table 5. Global Docetaxel Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Docetaxel Sales Share by Manufacturers (2016-2021)
Table 7. Global Docetaxel Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Docetaxel Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Docetaxel Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Docetaxel Manufacturing Sites and Area Served
Table 11. Manufacturers Docetaxel Product Type
Table 12. Global Docetaxel Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Docetaxel by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Docetaxel as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Docetaxel Sales by Region (2016-2021) & (K Units)
Table 16. Global Docetaxel Sales Market Share by Region (2016-2021)
Table 17. Global Docetaxel Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Docetaxel Sales by Country (2016-2021) & (K Units)
Table 19. North America Docetaxel Sales Market Share by Country (2016-2021)
Table 20. North America Docetaxel Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Docetaxel Revenue Market Share by Country (2016-2021)
Table 22. Europe Docetaxel Sales by Country (2016-2021) & (K Units)
Table 23. Europe Docetaxel Sales Market Share by Country (2016-2021)
Table 24. Europe Docetaxel Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Docetaxel Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Docetaxel Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Docetaxel Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Docetaxel Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Docetaxel Revenue Market Share by Region (2016-2021)
Table 30. Latin America Docetaxel Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Docetaxel Sales Market Share by Country (2016-2021)
Table 32. Latin America Docetaxel Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Docetaxel Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Docetaxel Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Docetaxel Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Docetaxel Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Docetaxel Revenue Market Share by Country (2016-2021)
Table 38. Global Docetaxel Sales (K Units) by Type (2016-2021)
Table 39. Global Docetaxel Sales Market Share by Type (2016-2021)
Table 40. Global Docetaxel Revenue (Million US$) by Type (2016-2021)
Table 41. Global Docetaxel Revenue Share by Type (2016-2021)
Table 42. Global Docetaxel Price (USD/Unit) by Type (2016-2021)
Table 43. Global Docetaxel Sales (K Units) by Application (2016-2021)
Table 44. Global Docetaxel Sales Market Share by Application (2016-2021)
Table 45. Global Docetaxel Revenue (Million US$) by Application (2016-2021)
Table 46. Global Docetaxel Revenue Share by Application (2016-2021)
Table 47. Global Docetaxel Price (USD/Unit) by Application (2016-2021)
Table 48. Hengrui Medicine Corporation Information
Table 49. Hengrui Medicine Description and Business Overview
Table 50. Hengrui Medicine Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Hengrui Medicine Docetaxel Product
Table 52. Hengrui Medicine Recent Developments/Updates
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Sanofi Docetaxel Product
Table 57. Sanofi Recent Developments/Updates
Table 58. Qilu Pharma Corporation Information
Table 59. Qilu Pharma Description and Business Overview
Table 60. Qilu Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Qilu Pharma Docetaxel Product
Table 62. Qilu Pharma Recent Developments/Updates
Table 63. Shenzhen Main Luck Pharma Corporation Information
Table 64. Shenzhen Main Luck Pharma Description and Business Overview
Table 65. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Shenzhen Main Luck Pharma Docetaxel Product
Table 67. Shenzhen Main Luck Pharma Recent Developments/Updates
Table 68. Jiangsu Aosaikang Pharma Corporation Information
Table 69. Jiangsu Aosaikang Pharma Description and Business Overview
Table 70. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Jiangsu Aosaikang Pharma Docetaxel Product
Table 72. Jiangsu Aosaikang Pharma Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Docetaxel Distributors List
Table 76. Docetaxel Customers List
Table 77. Docetaxel Market Trends
Table 78. Docetaxel Growth Drivers
Table 79. Docetaxel Market Restraints
Table 80. Global Docetaxel Sales Forecast by Type (2022-2027) & (K Units)
Table 81. Global Docetaxel Sales Market Share Forecast by Type (2022-2027)
Table 82. Global Docetaxel Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 83. Global Docetaxel Revenue Market Share Forecast by Type (2022-2027)
Table 84. Global Docetaxel Sales Forecast by Application (2022-2027) & (K Units)
Table 85. Global Docetaxel Sales Market Share Forecast by Application (2022-2027)
Table 86. Global Docetaxel Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 87. Global Docetaxel Revenue Market Share Forecast by Application (2022-2027)
Table 88. Global Docetaxel Sales Forecast by Region (2022-2027) & (K Units)
Table 89. Global Docetaxel Sales Market Share Forecast by Region (2022-2027)
Table 90. Global Docetaxel Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 91. Global Docetaxel Revenue Market Share Forecast by Region (2022-2027)
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Docetaxel
Figure 2. Global Docetaxel Market Share by Type in 2020 & 2027
Figure 3. 20 mg/ml Product Picture
Figure 4. 40 mg/ml Product Picture
Figure 5. 60 mg/ml Product Picture
Figure 6. Global Docetaxel Market Share by Application in 2020 & 2027
Figure 7. Breast Cancer
Figure 8. Prostate Cancer
Figure 9. Non-small Cell Lung Cancer
Figure 10. Others
Figure 11. Global Docetaxel Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Docetaxel Market Size 2016-2027 (US$ Million)
Figure 13. Global Docetaxel Sales 2016-2027 (K Units)
Figure 14. Global Docetaxel Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Docetaxel Sales Share by Manufacturers in 2020
Figure 16. Global Docetaxel Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Docetaxel Players: Market Share by Revenue in 2020
Figure 18. Docetaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Docetaxel Sales Market Share by Region (2016-2021)
Figure 20. Global Docetaxel Sales Market Share by Region in 2020
Figure 21. Global Docetaxel Revenue Market Share by Region (2016-2021)
Figure 22. Global Docetaxel Revenue Market Share by Region in 2020
Figure 23. U.S. Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Docetaxel Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Docetaxel by Type (2016-2021)
Figure 48. Sales Market Share of Docetaxel by Application (2016-2021)
Figure 49. Sales Market Share of Docetaxel by Application in 2020
Figure 50. Revenue Share of Docetaxel by Application (2016-2021)
Figure 51. Revenue Share of Docetaxel by Application in 2020
Figure 52. Manufacturing Cost Structure of Docetaxel
Figure 53. Manufacturing Process Analysis of Docetaxel
Figure 54. Docetaxel Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.